Madrigal Pharma (MDGL) Announces Delay in Release of Topline Results from the Phase 3 MAESTRO-NAFLD-1 Clinical Trial of Resmetirom

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/26/2026

1. ON
2. SYNA
3. SPY
4. MU
5. DRI
6. NKE
7. NVDA
8. FDXF
9. SPCX
10. INCY

Go back to Madrigal Pharma (MDGL) Announces Delay in Release of Topline Results from the Phase 3 MAESTRO-NAFLD-1 Clinical Trial of Resmetirom

No Negative in Madrigal Pharma's (MDGL) Topline Data Delay - H. C. Wainwright

December 30, 2021 11:02 AM EST

Earlier today, Madrigal Pharma (NASDAQ: MDGL) announced delay in release... More